
Genext Genomics
Nagpur, India genextgenomics.com From their website, Nov 2026
Work here? Claim this listing
About
Genext Genomics Pvt Ltd is a life science research company and contract research organization in central India. It develops recombinant proteins, monoclonal antibodies, cell lines, and diagnostic assays for research, diagnostic, and therapeutic applications.
Services
Recombinant protein services
Custom expression, purification, characterization, and scale-up of recombinant proteins using bacterial and mammalian expression systems.
Protein production
Antibody services
Custom antibody development, production, and purification for research and diagnostic applications.
Assay development services
Custom ELISA, lateral flow, western blot, and immunohistochemistry assay development, validation, and scale-up.
Monoclonal antibody development
Mouse monoclonal antibody development from antigen preparation and immunization through fusion, subcloning, production, purification, and hybridoma delivery.
Recombinant antibody development
Design, sequence optimization, cloning, expression, purification, and QC of recombinant antibodies.
Cell line development
CHO cell line development using CHO-GS, CHOZN, and UCOE gene expression systems to generate research cell banks and production cell lines.
Cell line development
Novel antibody discovery
Phage display-based discovery of high-affinity antibodies using the proprietary HIND human immune naïve discovery antibody library platform.
Bacterial expression systems (E. coli)
Protein expression and purification services using E. coli for scalable, cost-effective recombinant protein production.
Protein production
3 more services
- Mammalian cell expression systems (CHO, HEK293)
- Monoclonal antibodies production
- Custom services
- Turnaround
- 2 months to 12 weeks
- What to send
- Vector created for the chosen host cell
- Antigen for immunization
- Specific target for phage display screening
Capabilities
- Assays and studies
- Antibodies
- Phage display
- Mammalian expression
- CHO
- E. coli expression
- HEK293
11 more
- Hybridoma
- ELISA
- Lateral flow assay
- Western blot
- Immunohistochemistry
- Flow cytometry
- Immunoprecipitation
- Bioanalytical characterization
- ELISA screening
- Biopanning
- Functional assay
- Scale and capacity
- Milligram to gram quantities
- Up to 40-60 million cells/mL
- Research Cell Bank in 9-12 weeks
- Protein titers up to 8 g/L
- Scale-up production from milligram to gram quantities
- Therapeutic areas
- Inflammation
- Cancer
- Infectious disease
- Kidney disease
- Zoonotic disease
- Drug discovery
- Diagnostics
- Therapeutic proteins
Modalities and species
- Modalities
- Small molecule
- Antibody
- Recombinant protein
- Biosimilar
- Species and models
- E. coli
- CHO
- HEK293
- BALB/c mice
- Mouse hybridoma
- Rabbit
4 more
- Rat
- Hybridoma
- Bacteriophages
- B cells from native or immune donors
Industries served
- Biotech
- Life science research
- Diagnostics
- Veterinary
- Agriculture
Company
- Type
- CRO
- Founded
- 2011
- Quality
- ISO 9001:2015 (custom antibody production services and diagnostic solutions) · DSIR Recognized (research based company) · Recognized as a place of research by Dat
Locations
- Based in
- Nagpur, India
- Serves
- India
Contacts
- General enquiry
- info@genextgenomics.com on their site
- Phone
- +91 87998 29691
Public records
- Parent company
- GENEXT GENOMICS PRIVATE LIMITED · IN GLEIF